0
0

Chapter 14. Movement Disorders

Burton Scott, Ph.D., M.D.
DOI: 10.1176/appi.books.9781585623754.391510

Sections

Excerpt

As people age, a variety of movement disorders can either appear for the first time or progress after onset earlier in life. Arthritis, bursitis, tendonitis, and other non–central nervous system conditions can in some ways mimic neurological conditions by causing stooped posture and overall slowing of movement. In this chapter, I discuss central nervous system–based movement disorders that occur in elderly individuals and result in impaired or abnormal movement.

Your session has timed out. Please sign back in to continue.
Sign In Your Session has timed out. Please sign back in to continue.
Sign In to Access Full Content
 
Username
Password
Sign in via Athens (What is this?)
Athens is a service for single sign-on which enables access to all of an institution's subscriptions on- or off-site.
Not a subscriber?

Subscribe Now/Learn More

PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing PsychiatryOnline@psych.org or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Table Reference Number
Table 14–1. Clinical features of parkinsonism
Table Reference Number
Table 14–2. Differential diagnosis of parkinsonism
Table Reference Number
Table 14–3. Motor complications of Parkinson's disease
Table Reference Number
Table 14–4. Nonmotor features of Parkinson's disease
Table Reference Number
Table 14–5. Medical treatment of Parkinson's disease

References

Benito-Leon J, Louis ED: Clinical update: diagnosis and treatment of essential tremor. Lancet 369:1152–1154, 2007
[PubMed]
 
Chouinard G, Jones B, Remington G, et al: Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients. J Clin Psychopharmacol 13:25–40, 1993
[PubMed]
 
de Bruin VMS, Lees AJ, Daniel SE: Diffuse Lewy body disease presenting with supranuclear gaze palsy, parkinsonism, and dementia: a case report. Mov Disord 7:355–358, 1992
 
DeLeon ML, Jankovic J: Clinical features and management of tardive dyskinesias, tardive myoclonus, tardive tremor, and tardive tourettism, in Drug Induced Movement Disorders. Edited by Sethi K. New York, Marcel Dekker, 2004, pp 77–109
 
Forno LS: Neuropathology of Parkinson's disease. J Neuropathol Exp Neurol 55:259–272, 1996
[PubMed]
 
Foster NL, Wilhelmsen K, Sima AAF, et al: Frontotemporal dementia and parkinsonism linked to chromosome 17: a consensus conference. Participants of the Chromosome 17–Related Dementia Conference. Ann Neurol 41:706–715, 1997
[PubMed]
 
Gibb WRG, Luthert PJ, Marsden CD: Clinical and pathological features of corticobasal degeneration. Adv Neurol 53:51–54, 1990
[PubMed]
 
Golbe LI: Alpha-synuclein and Parkinson's disease. Mov Disord 14:6–9, 1999
[PubMed]
 
Golbe LI, Davis PH: Progressive supranuclear palsy, in Parkinson's Disease and Movement Disorders, 2nd Edition. Edited by Jankovic J, Tolosa E. Baltimore, MD, Williams & Wilkins, 1993, pp 145–161
 
Hallett M, Fahn S, Jankovic J, et al (eds): Psychogenic Movement Disorders: Neurology and Neuropsychiatry. Philadelphia. Lippincott Williams & Wilkins, 2006
 
Jankovic J: Progressive supranuclear palsy: clinical and pharmacologic update. Neurol Clin 2:473–486, 1984
[PubMed]
 
Jankovic J: Essential tremor: clinical characteristics. Neurology 54:S21–S25, 2000
 
Jankovic J, Friedman DI, Pirozzolo FJ, et al: Progressive supranuclear palsy: motor, neurobehavioral, and neuro-ophthalmic findings. Adv Neurol 53:293–304, 1990
[PubMed]
 
Koller WC, Lang A, Vetere-Overfield B, et al: Psychogenic tremors. Neurology 39:1094–1099, 1989
[PubMed]
 
Kraft E, Schwarz J, Trenkwalder C, et al: The combination of hypointense and hyperintense signal changes on T2-weighted magnetic resonance sequences: a specific marker for multiple system atrophy? Arch Neurol 56:225–228, 1999
[PubMed]
 
Lang AE, Lozano AM: Parkinson's disease: first of two parts. N Engl J Med 339:1044–1053, 1998a
 
Lang AE, Lozano AM: Parkinson's disease: second of two parts. N Engl J Med 339:1130–1143, 1998b
 
Litvan I: Progressive supranuclear palsy revisited. Acta Neurol Scand 98:73–84, 1998
[PubMed]
 
Litvan I, Agid Y, Calne D, et al: Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 47:1–9, 1996
[PubMed]
 
Litvan I, Agid Y, Goetz C, et al: Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study. Neurology 48:119–125, 1997
[PubMed]
 
Lund and Manchester Groups: Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatry 57:416–418, 1994
 
Meltzer HY: The mechanism of action of clozapine in relation to its clinical advantages, in Novel Antipsychotic Drugs. Edited by Meltzer HY. New York, Raven, 1992, pp 1–13
 
Mendis T, Mohr E, George A, et al: Symptomatic relief from treatment-induced psychosis in Parkinson's disease: an open-label pilot study with remoxipride. Mov Disord 9:197–200, 1994
[PubMed]
 
Miyasaki JM, Shannon K, Voon V, et al: Practice parameter: evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review). Neurology 66:996–1002, 2006
[PubMed]
 
Mutch WJ, Dingwall-Fordyce I, Downie AW, et al: Parkinson's disease in a Scottish city. Br Med J (Clin Res Ed) 292:534–536, 1986
[PubMed]
 
Myers BH, Scott BL: A case of combined orthostatic tremor and primary gait ignition failure. Clin Neurol Neurosurg 105:277–280, 2003
[PubMed]
 
Pahwa R, Factor SA, Lyons KE, et al: Practice parameter: Treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence-based review). Neurology 66:983–995, 2006
[PubMed]
 
Papapetropoulos S, Singer C: Botulinum toxin in movement disorders. Semin Neurol 27:183–194, 2007
[PubMed]
 
Patrick LR: Restless legs syndrome: pathophysiology and the role of iron and folate. Altern Med Rev 12:101–112, 2007
[PubMed]
 
Quinn NP: Multiple system atrophy, in Movement Disorders 3 (Butterworth-Heinemann International Medical Reviews. Neurology 12). Edited by Marsden CD, Fahn S. Boston, MA, Butterworth-Heinemann, 1994, pp 262–281
 
Riley DE, Lang AE: Clinical diagnostic criteria, in Corticobasal Degeneration (Advances in Neurology, Vol 82). Edited by Litvan I, Goetz CG, Lang AE. Philadelphia, PA, Lippincott Williams & Wilkins, 2000, pp 29–34
 
Savoiardo M, Grisoli M, Girotti F: Magnetic resonance imaging in CBD, related atypical parkinsonian disorders, and dementias, in Corticobasal Degeneration (Advances in Neurology, Vol 82). Edited by Litvan I, Goetz CG, Lang AE. Philadelphia, PA, Lippincott Williams & Wilkins, 2000, pp 197–208
 
Schneider JA, Watts RL, Gearing M, et al: Corticobasal degeneration: neuropathologic and clinical heterogeneity. Neurology 48:959–969, 1997
[PubMed]
 
Scott BL: Evaluation and treatment of dystonia. South Med J 93:746–751, 2000
[PubMed]
 
Scott BL, Jankovic J: Delayed-onset progressive movement disorders after static brain lesions. Neurology 46:68–74, 1996
[PubMed]
 
Sheppard DM, Bradshaw JL, Purcell R, et al: Tourette's and comorbid syndromes: obsessive compulsive and attention deficit hyperactivity disorder: a common etiology? Clin Psychol Rev 19:531–552, 1999
[PubMed]
 
Shulman LM, Weiner WJ: Multiple-system atrophy, in Movement Disorders: Neurologic Principles and Practice. Edited by Watts RL, Koller WC. New York, McGraw-Hill, 1997, pp 297–306
 
Shy GM, Drager GA: A neurological syndrome associated with orthostatic hypotension. Arch Neurol 2:511–527, 1960
[PubMed]
 
Steele JC, Richardson JC, Olszewski J: Progressive supranuclear palsy: a heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum, with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 10:333–359, 1964
[PubMed]
 
Suchowersky O, Gronseth G, Perlmutter J, et al: Practice parameter: neuroprotective strategies and alternative therapies for Parkinson disease (an evidence-based review). Neurology 66:976–982, 2006a
 
Suchowersky O, Reich S, Perlmutter J, et al: Practice parameter: diagnosis and prognosis of new onset Parkinson disease (an evidence-based review). Neurology 66:968–975, 2006b
 
Sutcliffe RL, Prior R, Mawby B, et al: Parkinson's disease in the district of the Northampton Health Authority, United Kingdom: a study of prevalence and disability. Acta Neurol Scand 72:363–379, 1985
[PubMed]
 
Tarsy D, Simon DK: Dystonia. N Engl J Med 355:818–829, 2006
[PubMed]
 
Vercueil L: Myoclonus and movement disorders. Neurophysiol Clin 36:327–331, 2006
 
Walker FO: Huntington's disease. Semin Neurol 27:143–150, 2007
[PubMed]
 
Wenning GK, Ben Shlomo Y, Magalhaes M, et al: Clinical features and natural history of multiple system atrophy: an analysis of 100 cases. Brain 117:835–845, 1994
[PubMed]
 
+

CME Activity

Add a subscription to complete this activity and earn CME credit.
Sample questions:
1.
Parkinsonism has been associated with the use of antipsychotic medications. Which of the following agents is least likely to produce parkinsonism symptoms?
2.
Parkinson's disease is a chronic, progressive, neurodegenerative illness that produces a constellation of motoric symptoms. Which of the following symptoms usually does not occur in Parkinson's disease?
3.
There are a number of motor complications of Parkinson's disease. Which of the following symptoms is usually secondary to medications used to treat Parkinson's disease?
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Related Content
Articles
Books
The American Psychiatric Publishing Textbook of Psychiatry, 5th Edition > Chapter 37.  >
The American Psychiatric Publishing Textbook of Geriatric Psychiatry, 4th Edition > Chapter 3.  >
The American Psychiatric Publishing Textbook of Geriatric Psychiatry, 4th Edition > Chapter 7.  >
The American Psychiatric Publishing Textbook of Geriatric Psychiatry, 4th Edition > Chapter 11.  >
The American Psychiatric Publishing Textbook of Geriatric Psychiatry, 4th Edition > Chapter 12.  >
Topic Collections
Psychiatric News
Read more at Psychiatric News >>
PubMed Articles
 
  • Print
  • PDF
  • E-mail
  • Chapter Alerts
  • Get Citation